Childhood chronic inflammatory demyelinating polyradiculoneuropathy: Combined analysis of a large cohort and eleven published series

Neuromuscular Disorders

Volumn 23, Issue 2, 2013, Pages 103-111

  McMillan, Hugh J ^a   Kang, Peter B ^b   Jones, H Royden ^b,c   Darras, Basil T ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Immunosuppressive agents; Intravenous immunoglobulins; Plasma exchange; Treatment outcome

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CROHN DISEASE; DISEASE COURSE; DISEASE DURATION; DRUG CHOICE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GROWTH DISORDER; HIRSUTISM; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MALE; MONOTHERAPY; MOON FACE; OUTCOME ASSESSMENT; PATIENT SELECTION; PLASMAPHERESIS; POLYRADICULONEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RECURRENT DISEASE; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOMODULATION; INFANT; MALE; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873101963     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.09.008     Document Type: Article

References (50)

1. Sladky J.T., Brown M.J., Berman P.H. Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder. Ann Neurol 1986, 20(1):76-81.
2. Nevo Y., Pestronk A., Kornberg A.J., et al. Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology 1996, 47(1):98-102.
3. McLeod J.G., Pollard J.D., Macaskill P., Mohamed A., Spring P., Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999, 46(6):910-913.
4. Koller H., Kieseier B.C., Jander S., Hartung H.P. Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 2005, 352(13):1343-1356.
5. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41(5):617-618.
6. Saperstein D.S., Katz J.S., Amato A.A., Barohn R.J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24(3):311-324.
7. Hughes R.A. Chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50(3):281-282.
8. Nevo Y., Topaloglu H. 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria), Naarden, The Netherlands, December 8-10, 2000. Neuromuscul Disord 2002, 12(2):195-200.
9. Rossignol E., D'Anjou G., Lapointe N., Haddad E., Vanasse M. Evolution and treatment of childhood chronic inflammatory polyneuropathy. Pediatr Neurol 2007, 36(2):88-94.
10. Ryan M.M., Grattan-Smith P.J., Procopis P.G., Morgan G., Ouvrier R.A. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 2000, 10(6):398-406.
11. Hattori N., Ichimura M., Aoki S., et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci 1998, 154(1):66-71.
12. Simmons Z., Wald J.J., Albers J.W. Chronic inflammatory demyelinating polyradiculoneuropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve 1997, 20(8):1008-1015.
13. Simmons Z., Wald J.J., Albers J.W. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve 1997, 20(12):1569-1575.
14. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics 1999, 30(4):190-196.
15. Vedanarayanan V.V., Kandt R.S., Lewis D.V., DeLong G.R. Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin. Neurology 1991, 41(6):828-830.
16. Rodriguez-Casero M.V., Shield L.K., Kornberg A.J. Subacute inflammatory demyelinating polyneuropathy in children. Neurology 2005, 64(10):1786-1788.
17. Uncini A., Parano E., Lange D.J., De V., Lovelace R.E. Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features. Childs Nerv Syst 1991, 7(4):191-196.
18. Colan R.V., Snead O.C., Oh S.J., Benton J.W. Steroid-responsive polyneuropathy with subacute onset in childhood. J Pediatr 1980, 97(3):374-377.
19. Pitt M. Maturational changes vis-à-vis neurophysiology markers and the development of peripheral nerves. Clinical neurophysiology of infancy, childhood and adolescence 2006, 146-167. Elsevier, Philadelphia. G.L. Holmes, S. Moshe, H.R. Jones (Eds.).
20. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., Van G.J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988, 19(5):604-607.
21. McCombe P.A., Pollard J.D., McLeod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 1987, 110(Pt 6):1617-1630.
22. Kleyweg R.P., van der Meche F.G. Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange. J Neurol Neurosurg Psychiatry 1991, 54(11):957-960.
23. Guillain-Barre Syndrome Steroid Trial Group Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Lancet 1993, 341(8845):586-590.
24. Ruts L., Drenthen J., Jacobs B.C., van Doorn P.A. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010, 74(21):1680-1686.
25. Dionne A., Nicolle M.W., Hahn A.F. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010, 41(2):202-207.
26. Ryan M.M., Tilton A., De G.U., Darras B.T., Jones H.R. Paediatric mononeuritis multiplex: a report of three cases and review of the literature. Neuromuscul Disord 2003, 13(9):751-756.
27. Duggins A.J., McLeod J.G., Pollard J.D., et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999, 122(Pt 7):1383-1390.
28. McMillan H.J., Miller E. Cranial nerve hypertrophy in pediatric chronic inflammatory demyelinating polyradiculoneuropathy. Pediatr Radiol 2010, 40(suppl 1):S176.
29. Mazzeo A., Stancanelli C., Russo M., et al. Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A. Muscle Nerve 2012, 45(3):451-452.
30. Vermeulen M., van Doorn P.A., Brand A., Strengers P.F., Jennekens F.G., Busch H.F. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993, 56(1):36-39.
31. Hahn A.F., Bolton C.F., Zochodne D., Feasby T.E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996, 119(Pt 4):1067-1077.
32. Thompson N., Choudhary P., Hughes R.A., Quinlivan R.M. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996, 243(3):280-285.
33. Mendell J.R., Barohn R.J., Freimer M.L., et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56(4):445-449.
34. Hughes R.A., Donofrio P., Bril V., et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol 2008, 7(2):136-144.
35. Dyck P.J., Litchy W.J., Kratz K.M., et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36(6):838-845.
36. Hughes R., Bensa S., Willison H., et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50(2):195-201.
37. Nobile-Orazio E., Cocito D., Jann S., et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol 2012, 11(6):493-502.
38. McMillan H.J., Darras B.T., Kang P.B. Autoimmune neuromuscular disorders in childhood. Curr Treat Options Neurol 2011, 13(6):590-607.
39. Brannagan T.H. Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve 2009, 39(5):563-578.
40. Grillo J.A., Gorson K.C., Ropper A.H., Lewis J., Weinstein R. Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders. Neurology 2001, 57(9):1699-1701.
41. Dyck P.J., O'Brien P.C., Oviatt K.F., et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982, 11(2):136-141.
42. Sladky J.T. What is the best initial treatment for childhood chronic inflammatory demyelinating polyneuropathy: corticosteroids or intravenous immunoglobulin?. Muscle Nerve 2008, 38(6):1638-1643.
43. Dyck P.J., Daube J., O'Brien P., et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986, 314(8):461-465.
44. Hahn A.F., Bolton C.F., Pillay N., et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 1996, 119(Pt 4):1055-1066.
45. Dalakas M.C., Engel W.K. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981, 9(suppl):134-145.
46. Dyck P.J., O'Brien P., Swanson C., Low P., Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy. Neurology 1985, 35(8):1173-1176.
47. Hughes R.A. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Expert Rev Neurother 2009, 9(6):789-795.
48. Gorson K.C., Amato A.A., Ropper A.H. Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Neurology 2004, 63(4):715-717.
49. Hughes R.A., Gorson K.C., Cros D. Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2010, 74(8):651-657.
50. Gorson K.C., Natarajan N., Ropper A.H., Weinstein R. Rituximab treatment in patients with IVIG-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 2007, 35(1):66-69.